NM_024079.5:c.1038+1G>T
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PVS1PP5
The NM_024079.5(ALG8):c.1038+1G>T variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000104 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024079.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- ALG8-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- polycystic liver disease 3 with or without kidney cystsInheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024079.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ALG8 | NM_024079.5 | MANE Select | c.1038+1G>T | splice_donor intron | N/A | NP_076984.2 | |||
| ALG8 | NM_001425224.1 | c.1131+1G>T | splice_donor intron | N/A | NP_001412153.1 | ||||
| ALG8 | NM_001425225.1 | c.1038+1G>T | splice_donor intron | N/A | NP_001412154.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ALG8 | ENST00000299626.10 | TSL:1 MANE Select | c.1038+1G>T | splice_donor intron | N/A | ENSP00000299626.5 | |||
| ALG8 | ENST00000679559.1 | c.1038+1G>T | splice_donor intron | N/A | ENSP00000505433.1 | ||||
| ALG8 | ENST00000532440.6 | TSL:3 | c.1038+1G>T | splice_donor intron | N/A | ENSP00000433429.2 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152132Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000263 AC: 66AN: 251416 AF XY: 0.000258 show subpopulations
GnomAD4 exome AF: 0.000101 AC: 148AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.000113 AC XY: 82AN XY: 727230 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000131 AC: 20AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74318 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Polycystic liver disease 3 with or without kidney cysts Pathogenic:1Uncertain:1
Familial cystic renal disease Pathogenic:1
The c.1038+1G>T variant in the ALG8 gene affects the invariant splice donor site of intron 10, a position critical for normal mRNA splicing. Alterations at this position are predicted to disrupt canonical splicing, likely resulting in aberrant transcripts and subsequent loss of function of the ALG8 protein. This variant has been previously reported in a patient with autosomal dominant polycystic liver disease (Besse et al., 2017), supporting its clinical relevance. Given that loss-of-function (LoF) is an established disease mechanism for ALG8-associated disorders, this variant satisfies PVS1. Additionally, it is extremely rare in population databases (allele frequency <0.01% in gnomAD v4.1.0), supporting PM2. Based on this evidence, the variant is classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at